글로벌 허리 통증 시장 – 2029년까지의 산업 동향 및 예측

허리 통증 시장 분석 및 규모

급성 요통은 근본적인 이유나 초기 손상으로 치료할 수 있지만 만성 요통은 12주 이상 지속되어야 합니다. 만성 요통은 3개월 이상 지속되는 요통의 불편함입니다. 이 상태는 부상, 질병 또는 신체의 다양한 부위에 대한 스트레스로 인해 발생할 수 있습니다. 통증은 매우 다양할 수 있으며 뼈 통증, 근육 통증 또는 신경 통증으로 나타날 수 있습니다.

Data Bridge Market Research는 2021년에 8,812.01백만 달러였던 요통 시장이 2029년까지 13421.46백만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지 예측 기간 동안 5.40%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

허리 통증 시장 범위 및 세분화   

시장 정의

Nearly everyone has experienced lower back discomfort at some point. Basically, it is a sort of muscle tension, pain, or rigidity that is present above the gluteal sulcus and below the bottom margin of the rib cage. It may be brought on by a strain (injury) to the back's muscles or tendons, arthritis, structural issues, or disc injuries. There are three different types of low back pain: acute, subacute, and chronic.

Lower Back Pain Market Dynamics

Drivers

• Increase in nerve cases

Demand for the lower back pain market is anticipated to be driven by an inactive lifestyle and an increase in nerve cases. The increased use of novel antidepressants and the rising elderly population are additional significant factors driving the market's expansion. Within the forecast period, the market is expected to experience new, attractive growth prospects due to rising research and development, particularly in the area of lower back pain.

• Rise in anti-inflammatory medications

Anti-inflammatory medications' negligible adverse effects are encouraging a rise in their use as painkillers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as non-steroidal anti-inflammatory treatments is aiding the industry's growth. Additionally, the lower doses of these medications are commonly accessible without a doctor's prescription. The market for lower back pain is anticipated to rise as a result of market participants' efforts to create novel NSAIDs that would lessen patients' pain.

• Rising number of individuals

The expansion of the market is being aided by the rising number of individuals in the area who suffer from persistent lower back pain. The market growth for chronic lower back pain treatment in North America is quickening due to rising healthcare spending by the populace and the presence of cutting-edge healthcare infrastructure. In the upcoming years, it is projected that growing research efforts to identify the root causes of chronic lower back pain and create better treatment alternatives will spur market expansion.

Opportunities

The primary growth drivers for the chronic lower back pain market are an increase in the frequency of nerve instances and an increase in the senior population. For instance, the National Institute of Neurological disorders and stroke reports that roughly 80% of adults have this type of low back discomfort at some point in their lives. Inactivity, expanding healthcare awareness in developed and developing nations, and rising consumer disposable income are further factors anticipated to promote market expansion.

Restraints/Challenges

On the other hand, the high cost associated with drug development will obstruct the market's growth rate. The stringent regulatory policies will also restrain the market growth rate during the forecast period of 2022-2029.

This lower back pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lower back pain market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Lower Back Pain Market

As older patients make up a large portion of COVID-19 patients with severe symptoms, these older patients frequently endure chronic pain even in the absence of COVID-19 infection. Thus, the virus may not be to blame for the increased neurologic symptoms. The reported increase in discomfort among COVID-19 patients might simply be a temporary ailment. Similar to the flu, the pain would only become noticeable during the acute infection. The accounts of post-COVID condition would not be explained by this, though.

Global Lower Back Pain Market Scope

The lower back pain market is segmented on the basis of disease type, type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Disease Type

• Acute
• Sub-Acute
• Chronic

 Type

• Diagnosis
• Treatment

End User

• Hospitals
• Orthopaedic Clinics
• Ambulatory Surgery Centres
• Others

 Distribution Channel

• Direct
• Retail

Lower Back Pain Market Regional Analysis/Insights

The lower back pain market is analysed and market size insights and trends are provided by country, disease type, type, end user and distribution channel as referenced above.

The countries covered in the lower back pain market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the lower back pain market due to increased awareness over the availability of different treatment procedures.

Asia-Pacific is anticipated to have a fastest growth rate in the forecast period of 2022 to 2029 due to the rapidly growing expenditure on healthcare facilities by government and increasing geriatric population.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 요통 시장 점유율 분석

허리 통증 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 프로그램 우세입니다. 위에 제공된 데이터 포인트는 허리 통증 시장과 관련된 회사의 초점에만 관련이 있습니다.

허리 통증 시장에서 활동하는 주요 업체는 다음과 같습니다.

• 파이저 주식회사(미국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 사노피(프랑스)
• 엔도제약(아일랜드)
• 머크앤코 주식회사(미국)
• Dr. Reddy's Laboratories Ltd. (인도)
• Vertebral Technologies, Inc. (미국)
• 메드트로닉(아일랜드)
• 보스턴 사이언티픽 코퍼레이션(미국)
• 바이오웨이브 주식회사
• Koninklijke Philips NV(네덜란드)
• 아스텔라스파마 주식회사(일본)
• SpineThera Inc. (미국)
• 셀진 코퍼레이션(미국)
• Teva Pharmaceutical Industries Ltd. (이스라엘)

SKU-46614